🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Basic objective of the German Adrenocortical Carcinoma Registry is to impro...
Status
Recruiting
Location
University of Wuerzburg
Start Date
2003-01-01
Trial ID
NCT00453674
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
Study Rationale Adrenocortical carcinoma (ACC) is a very rare disease with ...
Status
Unknown
Location
Medical Oncology Branch - Center for Cancer Research - National Cancer Institute
Start Date
2008-04
Trial ID
NCT00777244
Treatments Being Tested
To learn if adding pembrolizumab to mitotane can help to control ACC. The s...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2023-03-23
Trial ID
NCT05634577
Treatments Being Tested
The goal of this open-label randomized, multicenter, comparative phase II t...
Status
Recruiting
Location
Institut de Cancérologie de l'Ouest
Start Date
2024-07-23
Trial ID
NCT06333314
Treatments Being Tested
This phase III trial studies how well mitotane alone works compared to mito...
Status
Recruiting
Location
University of Michigan Comprehensive Cancer Center
Start Date
2018-08-20
Trial ID
NCT03583710
Treatments Being Tested
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Despite comp...
Status
Completed
Location
ASST Spedali Civili di Brescia
Start Date
2018-07-20
Trial ID
NCT03723941
Treatments Being Tested
This clinical trial is a single-arm, non-randomized, prospective phase II s...
Status
Recruiting
Location
S.C. Oncologia - ASST Spedali Civili di Brescia
Start Date
2025-09-18
Trial ID
NCT07085572
Treatments Being Tested
Adrenocortical carcinoma (ACC) is a rare aggressive malignant tumor. Accord...
Status
Recruiting
Location
West China Hospital
Start Date
2025-03-15
Trial ID
NCT06831175
Treatments Being Tested
This is a prospective randomized, double blind, placebo controlled phase II...
Status
Recruiting
Location
Alfredo Berruti
Start Date
2022-06-08
Trial ID
NCT05913427